H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Fort Lauderdale have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 182,760. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fort Lauderdale clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fort Lauderdale storefront.
Amniotic Membrane Wound Care Products in Fort Lauderdale, FL for clinics & physicians. Amniotic membrane w… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Fort Lauderdale is 30.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.8% of adults in Fort Lauderdale have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Florida includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for amniotic membrane wound care, not a walk-in clinic.
National Amniotic Membrane Wound Care Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.8% of adults in Fort Lauderdale have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Adult obesity in Fort Lauderdale is 30.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 24.4% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JN / First Coast Service Options, sibling states no other states. Florida Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Fort Lauderdale warehouse or a five-star local review. What you get is amniotic membrane wound care from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JN, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 30.3%; arthritis is 24.4%. That is place-level BRFSS modeling, not a clinic census and not a Fort Lauderdale trial.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. First Coast Service Options LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Florida clinician.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
If you operate in Florida and another MAC state, say it on the first call. JN will not port 1:1. We would rather split utilization than watch a sister clinic copy Fort Lauderdale tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Fort Lauderdale, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fort Lauderdale is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fort Lauderdale — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fort Lauderdale. Useful for joint-program math; still needs a diagnosis and privileging.
No Fort Lauderdale storefront. Joe Bradley is an active practice owner. amniotic membrane wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.